Related Experiment Video
Updated: Dec 18, 2025

Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
Rat postnatal prostate development is impaired by in vitro high-glucose environment
Isabella Silva Cassimiro1, Amanda Rodrigues Cruz1, Beatriz Pelegrini Bosque1
1Department of Cell Biology, Histology and Embriology, Institute of Biomedical Sciences - ICBIM, Federal University of Uberlândia, Uberlândia, Minas Gerai, Brazil.
Insights
High glucose levels during early prostate development impair gland growth by reducing cell proliferation and bud branching. This is linked to altered signaling pathways, impacting prostate formation in newborns.
Area of Science:
- Developmental Biology
- Endocrinology
- Cell Biology
Background:
- Prostate development involves significant cell proliferation and branching in the early postnatal period.
- Metabolic disturbances like hyperglycemia can negatively impact this critical developmental window.
- Hyperglycemia is prevalent in preterm infants and offspring of obese mothers, highlighting its potential impact on prostate health.
Purpose of the Study:
- To investigate the in vitro effects of elevated glucose concentrations on early postnatal prostate development.
- To analyze morphological and molecular changes in rat prostate tissue cultured under high glucose conditions.
Main Methods:
- Wistar rat prostates were cultured for 1-3 days in media with normal (5.5 mM) or high (7, 25 mM) glucose.
- Morphological analysis, immunohistochemistry (PCNA, smooth muscle α-actin), and gene expression (active caspase-3, ERK1/2, Wnt5a) were performed.
Main Results:
- High glucose reduced prostatic bud numbers and cell proliferation (PCNA).
- Elevated glucose decreased smooth muscle cell increase and collagen deposition.
- Active caspase-3 and TGF-β levels increased, while ERK1/2 activation decreased and Wnt5a expression increased under high glucose.
Conclusions:
- High glucose during early postnatal development inhibits prostate branching and growth by reducing cell proliferation.
- These effects are associated with decreased ERK1/2 activation and increased Wnt5a expression, indicating anti-proliferative signaling.
Abstract:
The prostate development has an important postnatal period where cell proliferation begins at the first days after birth and is related to gland growth and ramification. Any metabolic and/or hormonal changes occurring during the postnatal period can interfere with prostate branching. Hyperglycemia is a common condition in low-weight preterm babies at neonatal period and also a disorder found in the offspring of obese mothers. Thus, this study aimed to investigate the in vitro effects of a glucose-rich environment during prostate postnatal development. Wistar rats prostate were removed at birth and cultured for 1, 2 and 3 days in DMEM under normal (5.5 mM) or elevated (7 and 25 mM) glucose concentrations. Samples were processed for morphological analysis, PCNA and smooth muscle α-actin immunohistochemistry, evaluation of active caspase-3, ERK1/2 and Wnt5a gene expression. High glucose concentrations reduced the number of prostatic buds and proliferating cells. The natural increase in smooth muscle cells and collagen deposition observed in control prostates during the first 3 days of development was reduced by elevated glucose concentrations. The amount of active caspase-3 was higher in prostates incubated at 7 mM and TGF-β levels also increased sharply after both glucose concentrations. Additionally, high glucose environment decreased ERK 1/2 activation and increased Wnt5a expression. These data show that high levels of glucose during the first postnatal days affected prostate development by inhibiting cell proliferation which impairs bud branching and this was associated with anti-proliferative signals such as decreased ERK1/2 activation and increased Wnt5a expression.
More Related Videos
08:44Formation of Human Prostate Epithelium Using Tissue Recombination of Rodent Urogenital Sinus Mesenchyme and Human Stem Cells
Published on: June 22, 2013
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013